Neuroprotective Agents Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Neuroprotective Agents Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Report Description

Global Neuroprotective Agents Market is expected to grow at a CAGR of 6.8% from 2016 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Neuroprotective Agents Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2016 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:

KEY PLAYERS

AB SCIENCE S.A.

ACUCELA INC.

AERIE PHARMACEUTICALS INC.

ALLERGAN

ASTRAZENECA PLC

ATHERSYS INC.

AVEXIS INC.

BAYER HEALTHCARE

BIOGEN INC.

BRISTOL-MYERS SQUIBB CO.

BOEHRINGER INGELHEIM

BRAINSTORM CELL THERAPEUTICS INC.

CELGENE CORP.

CORESTEM INC.

COVIS PHARMA

DAIICHI SANKYO INC.

EISAI INC.

FORTRESS BIOTECH INC.

GENERVON BIOPHARMACEUTICALS LLC

GLAXOSMITHKLINE PLC

GW PHARMACEUTICALS PLC

H. LUNDBECK A/S

JANSSEN PHARMACEUTICALS INC.

MEDDAY PHARMACEUTICALS SAS

MERCK SERONO S.A.

MITSUBISHI PHARMA CORP.

NEWRON PHARMACEUTICALS SPA

NOVARTIS AG

PFIZER INC.

QUARK PHARMACEUTICALS INC.

REGENERON PHARMACEUTICALS INC.

RENEURON GROUP PLC

ROCHE HOLDING AG

SANOFI

TEVA PHARMACEUTICAL INDUSTRIES LTD.

UCB PHARMA S.A.

VERTEX PHARMACEUTICALS INC.

VTV THERAPEUTICS INC.

ZOGENIX INC.

Scope of the Market

Technology Type Market

Therapeutic Agents

Regenerative Medicine Products

Therapeutic Indication Market

Neuroprotective Agents for Cerebrovascular Disease

Neuroprotective Agents for Neurodegenerative Disorders

Neuroprotective Agents for Ophthalmic Diseases

Neuroprotective Agents for Traumatic Central Nervous System Injuries

Neuroprotective Agents-Based Drug Discovery and Development Industry

Neuroprotective Agents Biochip Industries

Geography Market

North America

Europe

Asia Pacific

Rest of the World (RoW)

Back to top

Payment Options

Single User : $3,897
Five User: $5,175
Enterprise : $9,135